Board of Directors

Iain Ross

Iain Ross 

Chairman & Non-Executive Director

Mr Iain Ross is an experienced multinational pharmaceutical and biotechnology executive and board member, and is currently Chairman of Silence Therapeutics plc (LSE & NASDAQ:SLN), ReNeuron Group plc (LSE:RENE) and BiVictriX Therapeutics plc (LSE:BVX).

During his career, Mr Ross has held senior positions at multinational companies, Sandoz AG, Hoffman La Roche, and Celltech Group PLC and been a Chairman, CEO and Director of several biotech companies. He is a qualified Chartered Director and former Vice Chairman of the Council of Royal Holloway, London University.

Mr Ross was appointed as a director of the Company in July 2015 and is considered to be an independent director.  He is a member of the Audit, Risk and Governance Committee and a member of the Remuneration and Nominations Committee.

Read more
Bryce Carmine

Bryce Carmine 

Non-Executive Director

Mr Bryce Carmine spent 36 years working for Eli Lilly & Co. and retired as Executive Vice President for Eli Lilly & Co, and President, Lilly Bio-Medicines. Prior to this he lead the Global Pharmaceutical Sales and Marketing and was a member of the company’s executive committee. He previously held a series of product development portfolio leadership roles culminating when he was named President, Global Pharmaceutical Product Development, with responsibility for the entire late-phase pipeline development across all therapeutic areas for Eli Lilly.

During his career with Lilly, Mr Carmine held several country leadership positions including President Eli Lilly Japan, Managing Dir. Australia/NZ & General Manager of a JV for Lilly in Seoul, Korea. He is currently Chairman and CEO of HaemaLogiX Pty Ltd, a Sydney-based privately owned biotech.

Mr Carmine was appointed as a director of the Company in June 2015 and is considered to be an independent director.  He is a member of the Audit, Risk and Governance Committee and Chair of the Remuneration and Nominations Committee.

Read more
Steven Coffey

Steven Coffey 

Non-Executive Director

Mr Steven Coffey is a Chartered Accountant, having spent his career in public practice since graduating from NSW University in 1983. He has been a partner in the chartered accounting firm Watkins Coffey Martin since 1993.

Mr Coffey is a registered company auditor and audits a number of large private companies as well as a number of not-for-profit entities. He has previously served on the board of an Australian listed public company and is currently a board member of two private ancillary funds (PAFs).

Mr Coffey was appointed as a director to the Company in November 2012 and is considered to be an independent director.  He is Chair of the Audit, Risk and Governance Committee and a member of the Remuneration and Nominations Committee.

Read more